CSL Limited's latest marketcap:
As of 06/26/2025, CSL Limited's market capitalization has reached $75.37 B. According to our data, CSL Limited is the 276th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 75.37 B |
| Revenue (ttm) | 16.06 B |
| Net Income (ttm) | 2.9 B |
| Shares Out | 484.21 M |
| EPS (ttm) | 5.97 |
| Forward PE | 22.35 |
| Ex-Dividend Date | 03/10/2025 |
| Earnings Date | 08/19/2025 |
CSL Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | A$75.37 B | -15.32% | 276 |
| 12/31/2024 | A$136.34 B | -1.54% | 201 |
| 12/29/2023 | A$138.48 B | -0.2% | 154 |
| 12/30/2022 | A$138.76 B | -0.3% | 137 |
| 12/31/2021 | A$139.18 B | 8.03% | 153 |
| 12/31/2020 | A$128.84 B | 2.94% | 134 |
| 12/31/2019 | A$125.16 B | 49.23% | 123 |
| 12/31/2018 | A$83.87 B | 31.24% | 152 |
| 12/29/2017 | A$63.91 B | 39.6% | 228 |
| 12/30/2016 | A$45.78 B | -6.09% | 299 |
Company Profile
About CSL Limited
CSL Limited is a global biopharmaceutical company specializing in research, development, manufacturing, and distribution of innovative biotherapies and vaccines. Headquartered in Melbourne, Australia, CSL operates across multiple regions, including the United States, Germany, the United Kingdom, Switzerland, and China.
Business Segments
- CSL Behring: Focuses on plasma-derived therapies, gene therapies, and recombinant products for rare and serious diseases.
- CSL Seqirus: A leader in influenza vaccines, providing seasonal and pandemic flu solutions to governments and healthcare providers.
- CSL Vifor: Specializes in treatments for iron deficiency and nephrology, addressing unmet medical needs in these therapeutic areas.
Company Overview
Founded in 1916, CSL Limited has grown into a trusted name in biopharmaceuticals, leveraging its intellectual property to advance medical science. The company remains committed to improving patient outcomes worldwide.
Frequently Asked Questions
-
What is CSL Limited's (ASX-CSL) current market cap?As of 06/26/2025, CSL Limited (including the parent company, if applicable) has an estimated market capitalization of $75.37 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CSL Limited (ASX-CSL) rank globally by market cap?CSL Limited global market capitalization ranking is approximately 276 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.